Lower serum caffeine levels may be of diagnostic significance in early Parkinson disease, consistent with epidemiologic data that support the neuro-protective properties of caffeine.
Bobby Lazzara, MD
Findings from a study lends credence to the role of lipids in the early stages of Alzheimer disease.
An incident, population-based prospective cohort study examined weight changes over time in patients with Parkinson disease.
Researchers conducted a retrospective analysis of patients with acute stroke and evaluated the effect of infection during the hospitalization period.
Low dose aspirin use is becoming almost ubiquitous in cardiovascular risk modification, cancer risk modification, and in other areas whether appropriately indicated…or not.
A study that compared motor and nonmotor outcomes of DBS for Parkinson disease may show promise for patients' quality of life.
A new study with longitudinal follow-up looked at disability trajectories after stroke compared with myocardial infarction.
A study of over 80,000 patients confirmed another strong reason to prevent young people from repetitive head blows.
In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.
A meta-analysis compared medical therapy with medical therapy plus angioplasty for the treatment of symptomatic vertebral artery stenosis.